Wave Life Sciences (WVE) EBIAT (2016 - 2025)
Historic EBIAT for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to -$53.9 million.
- Wave Life Sciences' EBIAT rose 1283.26% to -$53.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$121.9 million, marking a year-over-year increase of 1443.41%. This contributed to the annual value of -$97.0 million for FY2024, which is 6867.14% down from last year.
- According to the latest figures from Q3 2025, Wave Life Sciences' EBIAT is -$53.9 million, which was up 1283.26% from -$50.5 million recorded in Q2 2025.
- Wave Life Sciences' 5-year EBIAT high stood at $29.3 million for Q4 2024, and its period low was -$61.8 million during Q3 2024.
- Over the past 5 years, Wave Life Sciences' median EBIAT value was -$37.8 million (recorded in 2022), while the average stood at -$31.0 million.
- Examining YoY changes over the last 5 years, Wave Life Sciences' EBIAT showed a top increase of 27995.2% in 2024 and a maximum decrease of 95190.29% in 2024.
- Quarter analysis of 5 years shows Wave Life Sciences' EBIAT stood at -$34.8 million in 2021, then fell by 25.65% to -$43.7 million in 2022, then soared by 62.81% to -$16.3 million in 2023, then surged by 279.95% to $29.3 million in 2024, then plummeted by 284.09% to -$53.9 million in 2025.
- Its last three reported values are -$53.9 million in Q3 2025, -$50.5 million for Q2 2025, and -$46.9 million during Q1 2025.